Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03150056
Title Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90033 United States Details
GSK Investigational Site Baltimore Maryland 21287 United States Details
GSK Investigational Site Towson Maryland 21204 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site Madison Wisconsin 53792 United States Details
GSK Investigational Site Sydney New South Wales 2050 Australia Details
GSK Investigational Site Clayton Victoria 3168 Australia Details
GSK Investigational Site Melbourne Victoria 3000 Australia Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 8036 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Malaga 3075EA Spain Details
GSK Investigational Site Sabadell (Barcelona) 08208 Spain Details
GSK Investigational Site Santander 39008 Spain Details
GSK Investigational Site Sutton London SM2 5NG United Kingdom Details
GSK Investigational Site Glasgow G12 OYN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field